Article

Anthem More Than Doubled the Members Receiving Whole-Person Treatment for Opioid Use Disorder

Innovative providers, collaborations and payment strategies credited for increase.

Indianapolis—Anthem Blue Cross and Blue Shield more than the doubled the number of members in Medicaid, individual and employer-sponsored plans receiving whole-person therapies believed to produce better outcomes for opioid use disorder.

To make a positive impact on member health and lessen the impact of the opioid epidemic, Anthem pledged four years ago to ensure significantly more members received both drug therapy and counseling treatment in an effort to treat both mind and body.

Anthem met these goals by boosting the combined percentage of consumers in employer-based, individual and Medicaid plans with opioid use disorder receiving both therapies from 22% to 56%. Medicaid plans alone increased from 24% to 65%.

Learn more.

Related Videos
Robin Glasco, MBA
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program
Screenshot of an interview with Nadine Barrett, PhD
Neil Goldfarb, GPBCH
Dr Bonnie Qin
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
dr carol regueiro
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo